Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Lymphography with Exercise for Lymphedema
NCT03584633Phase 4
Key facts
- Status
- Completed
- Start
- Apr 2019
- Primary completion
- Sep 2019
- Countries
- 1
- Sponsor
- University of Iowa
- Modality
- Small Molecules
- Drugs
- indocyanine green
- Conditions
- lymphedema
01
Overview
Phase 4, open-label trial of indocyanine green in lymphedema, sponsored by University of Iowa. Primary endpoint: Time for Initial Disease Pattern to Appear at 1 minute. Started Apr 2019; status: completed.
02
Design
- Study design
- Non-randomizedOpen-labelSingle group
03
Who it enrols
Female patients aged 18-85 with suspected or diagnosed lymphedema, excluding those with iodine allergies, pregnancy, or heart/lung/joint conditions preventing exercise.
04
Endpoints
Primary
Time for Initial Disease Pattern to Appear
Secondary
Time to Reach Indocyanine Green Lymphography Steady State
Beyond the preview
Go deeper on NCT03584633.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03584633.